MyFinsight
Home
Blog
About
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$6,551K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Stock-based compensation expense
Accrued compensation
Others
Negative Cash Flow Breakdown
Personnel costs
Purchases of marketable investme...
Organizational and marketing cos...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenues from external customers
103,546
83,679
87,010
83,043
Personnel costs
60,349
58,367
53,202
52,863
Organizational and marketing costs
16,029
15,594
11,562
39,983
Inventory usage
8,450
6,437
5,505
6,127
Clinical studies and publication costs
2,103
2,542
2,586
2,183
Professional services
2,669
3,007
2,530
2,524
Other segment items
16,006
12,254
13,957
8,580
Net loss
-2,060
-14,522
-2,332
-501
Depreciation and amortization
4,070
3,929
3,777
3,816
Stock-based compensation expense
11,589
9,776
11,406
12,100
Change in fair value of equity securities
-
-
-
3,561
Net (gains) losses on equity securities
-630
2,022
1,466
-
Deferred income taxes
-3
-10
-907
116
Accretion of discounts on marketable investment securities
392
454
708
905
Other
-235
-532
129
-63
Accounts receivable
5,817
-1,075
-6,272
-1,911
Prepaid expenses and other current assets
877
6,667
-3,991
-161
Inventory
119
207
1,604
307
Operating lease assets
-228
-371
-356
-352
Other assets
258
530
312
41
Accounts payable
-2,307
3,193
-17
1,406
Operating lease liabilities
-59
-172
-209
-197
Accrued compensation
7,782
-19,176
6,524
6,790
Other accrued and current liabilities
2,559
2,755
-1,032
1,428
Net cash (used in) provided by operating activities
15,201
-22,129
26,931
22,631
Purchases of marketable investment securities
54,486
55,136
37,408
58,474
Proceeds from maturities of marketable investment securities
41,000
39,100
54,000
54,900
Proceeds from maturities of debt securities classified as held-to-maturity
5,600
-
-
-
Purchases of debt securities classified as held-to-maturity
0
0
0
0
Proceeds from sale of equity securities
567
2,681
1,533
-
Asset acquisition, net of cash and cash equivalents acquired
0
-
1
0
Issuance of loan receivable
-
-
2,114
-
Purchases of property and equipment
8,650
12,455
7,184
14,834
Proceeds from sale of property and equipment
6
7
5
19
Net cash used in investing activities
-15,963
-25,803
8,831
-18,389
Proceeds from exercise of common stock options
95
322
2,092
77
Payment of employees taxes on vested restricted stock units and performance-based restricted stock units
793
6,598
7,368
1,185
Proceeds from contributions to the employee stock purchase plan
836
1,267
714
220
Payment of contingent consideration
1,000
-
-
-
Repayment of principal portion of finance lease liabilities
24
24
27
31
Proceeds from lease incentives received
0
-
0
0
Proceeds from issuance of term debt
-
-
0
0
Net cash used in financing activities
-886
-5,033
-4,589
-919
Net change in cash and cash equivalents
-1,648
-52,965
31,173
3,323
Beginning of period
63,764
116,729
85,556
119,709
End of period
62,116
63,764
116,729
85,556
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Stock-based compensation
expense
$11,589K
(-48.23%↓ Y/Y)
Accrued compensation
$7,782K
(202.64%↑ Y/Y)
Depreciation and
amortization
$4,070K
(-87.73%↓ Y/Y)
Other accrued and
current liabilities
$2,559K
(439.87%↑ Y/Y)
Net (gains) losses
on equity...
-$630K
Other
-$235K
(-7.31%↓ Y/Y)
Operating lease assets
-$228K
(65.66%↑ Y/Y)
Net cash (used in)
provided by operating...
$15,201K
(2.81%↑ Y/Y)
Canceled cashflow
$11,892K
Net revenues from
external customers
$103,546K
(-40.55%↓ Y/Y)
Net change in cash
and cash...
-$1,648K
(95.60%↑ Y/Y)
Canceled cashflow
$15,201K
Proceeds from maturities
of marketable...
$41,000K
(-48.94%↓ Y/Y)
Proceeds from maturities
of debt securities...
$5,600K
Proceeds from sale of
equity securities
$567K
Proceeds from sale of
property and equipment
$6K
(-71.43%↓ Y/Y)
Proceeds from
contributions to the employee...
$836K
(-43.59%↓ Y/Y)
Proceeds from exercise of
common stock options
$95K
(156.76%↑ Y/Y)
Accounts receivable
$5,817K
(345.07%↑ Y/Y)
Accounts payable
-$2,307K
(-236.59%↓ Y/Y)
Net loss
-$2,060K
(90.34%↑ Y/Y)
Prepaid expenses and
other current assets
$877K
(-81.32%↓ Y/Y)
Accretion of discounts on
marketable investment...
$392K
(-84.96%↓ Y/Y)
Other assets
$258K
(1884.62%↑ Y/Y)
Inventory
$119K
(-48.48%↓ Y/Y)
Operating lease
liabilities
-$59K
(93.21%↑ Y/Y)
Deferred income taxes
-$3K
(99.94%↑ Y/Y)
Canceled cashflow
$103,546K
Net cash used in
investing activities
-$15,963K
(68.58%↑ Y/Y)
Canceled cashflow
$47,173K
Net cash used in
financing activities
-$886K
(38.98%↑ Y/Y)
Canceled cashflow
$931K
Personnel costs
$60,349K
(-41.83%↓ Y/Y)
Organizational and marketing
costs
$16,029K
Other segment items
$16,006K
(-62.74%↓ Y/Y)
Inventory usage
$8,450K
(-17.07%↓ Y/Y)
Professional services
$2,669K
(-54.56%↓ Y/Y)
Clinical studies and
publication costs
$2,103K
(-47.53%↓ Y/Y)
Purchases of marketable
investment securities
$54,486K
(-41.31%↓ Y/Y)
Purchases of property and
equipment
$8,650K
(-38.23%↓ Y/Y)
Payment of contingent
consideration
$1,000K
Payment of employees
taxes on vested...
$793K
(-74.45%↓ Y/Y)
Repayment of principal
portion of finance lease...
$24K
(-57.89%↓ Y/Y)
Buy us a coffee